Director Stein Jeffrey purchased 50,000 shares of IDYA at $32.96, raising holdings to 54,281 shares (+1168.0%)
Stein Jeffrey, a director at IDEAYA Biosciences, executed a substantial open-market purchase of 50,000 shares at $32.96 on 2026-03-02, with a total transaction value of $1,647,890.00. This acquisition increased his shareholding from 4,281 shares to 54,281 shares—a 1168.0% increase—representing a material deepening of his ownership stake in the company. The transaction occurred at a price approximately 0.24% below the current market price of $33.04 and reflects a buy decision made while the stock trades 12.7% below its 52-week high of $37.86. Notably, this contrasts with the company's recent fundamental position: while the latest quarter showed revenue of $207,834,000.00 and net income of $119,244,000.00, the company was unprofitable over its most recent full fiscal year despite posting extraordinary revenue growth of +3024.4% year-over-year. The magnitude of the position increase and the timing relative to this financial backdrop merit investor attention to track whether the director's expanded commitment proves well-founded.